Replies to post #292794 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

Wasn't fake news at all, was it?.....Gilead said it was just anecdotal and statistically insufficient.

"Gilead spokesman Chris Ridley said in an emailed statement to Barron’s that the company expects data from its Phase 3 study in patients with severe Covid-19 infections to be available at the end of April, with additional data from other studies coming in May.

“We understand the urgent need for a COVID-19 treatment and the resulting interest in data on our investigational antiviral drug remdesivir,” Ridley said. “The totality of the data need to be analyzed in order to draw any conclusions from the trial. Anecdotal reports, while encouraging, do not provide the statistical power necessary to determine the safety and efficacy profile of remdesivir as a treatment for COVID-19.”"

https://www.statnews.com/2020/04/16/early-peek-at-data-on-gilead-coronavirus-drug-suggests-patients-are-responding-to-treatment/

https://www.barrons.com/articles/stock-futures-soar-on-gilead-coronavirus-drug-report-51587079853